Paper36944290
Loss of amyotrophic lateral sclerosis risk factor SCFD1 causes motor dysfunction in Drosophila.
Borg R and 4 others. Neurobiol Aging, 2023. Cited by 12 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Loss of amyotrophic lateral sclerosis risk factor SCFD1 causes motor dysfunction in Drosophila. Papers, record 36944290. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36944290
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Loss of amyotrophic lateral sclerosis risk factor SCFD1 causes motor dysfunction in Drosophila.
- PubMed
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Amyotrophic Lateral Sclerosis | Major topic |
| Animals | |
| Drosophila | |
| Genome-Wide Association Study | |
| Risk Factors | |
| Disease Models, Animal |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,809,650 | Motor dysfunction phenotypes in a drosophila model validate DAO as an ALS gene. | Hum Mol Genet | 2026 | https://conductscience.org/library/papers/42809650 | PubMed |
| 41,466,038 | ALS: a field in motion. | Sci Rep | 2025 | https://conductscience.org/library/papers/41466038 | PubMed |
| 41,009,783 | Deciphering European Sea Bass (Dicentrarchus labrax) Resistance to Nervous Necrosis Virus by Transcriptome Analysis from Early Infection Towards Establishment of Virus Carrier State. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009783 | PubMed |
| 39,294,626 | Identification of novel genetic loci related to dromedary camel (Camelus dromedarius) morphometrics, biomechanics, and behavior by genome-wide association studies. | BMC Vet Res | 2024 | https://conductscience.org/library/papers/39294626 | PubMed |
| 39,106,308 | Anaplasma phagocytophilum effector EgeA facilitates infection by hijacking TANGO1 and SCFD1 from ER-Golgi exit sites to pathogen-occupied inclusions. | Proc Natl Acad Sci U S A | 2024 | https://conductscience.org/library/papers/39106308 | PubMed |
| 38,396,996 | Unraveling the Genetic Landscape of Neurological Disorders: Insights into Pathogenesis, Techniques for Variant Identification, and Therapeutic Approaches. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38396996 | PubMed |
| 37,360,176 | Reduced levels of ALS gene DCTN1 induce motor defects in Drosophila. | Front Neurosci | 2023 | https://conductscience.org/library/papers/37360176 | PubMed |
| 37,148,340 | Identifying novel genes for amyotrophic lateral sclerosis by integrating human brain proteomes with genome-wide association data. | J Neurol | 2023 | https://conductscience.org/library/papers/37148340 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36944290
GET https://conductscience.org/api/papers/v1/36944290/authors